News & Events

In celebration of its first quarter century, the journal Immunity asked 25 principal investigators to share their views on how immunology research could evolve over the next 25 years.

Applications are now being accepted for the 2019 IDEA² Global program! Deadline is April 16, 2019. Open to postdoctoral trainees, graduate students, undergraduates, faculty, early-stage professionals, and those with limited opportunities to pursue their innovative projects, IDEA² Global provides one-on-one mentorship, innovation training, pitch-skills development, and international networking opportunities to aspiring healthcare…

Video game developer NCSOFT joins with MIT.nano to apply the language of gaming to technology research and education. A new collaboration between MIT.nano and NCSOFT, a video game development company based in South Korea, will seek to chart the future of how people interact with the world and each other…

The following press release was issued today by the Broad Institute of MIT and Harvard. A group of academic institutions has granted a license for SHERLOCK™, the highly-sensitive, low-cost CRISPR-based diagnostic, for commercial uses in the developed world, while reserving rights to enable its broad use by organizations to serve…

Isha H. Jain, MEMP PhD ’17, and Kristin Knouse, HST MD ’18 and MIT Biology PhD ’17, are two of twelve recipients of the 2018 National Institutes of Health Director’s Early Independence Award. The award supports junior scientists who possess “the intellect, scientific creativity, drive, and maturity to flourish independently.”…

For her 20 years of dedication to cultivating a workplace that fosters diverse viewpoints and open collaboration, IMES Principal Research Scientist Mercedes Balcells-Camps has won a 2019 MIT Excellence Award for “Advancing Inclusion and Global Perspectives”. She will be celebrated alongside other MIT Excellence Award winners and Collier Medal recipients…

Studies could speed the development of new treatments for liver disease. Novel therapies based on a process known as RNA interference (RNAi) hold great promise for treating a variety of diseases by blocking specific genes in a patient’s cells.

The GOSSIS algorithm was developed using data from hospitals around the world to spur greater multi-center collaboration and improved benchmarking. A man with a history of cardiac arrhythmia is admitted to an emergency room in Virginia, with symptoms of chest pain and irregular heartbeat. Based on factors such as age,…

This past January, we traveled to South Africa as part of the IAP class HST.434: Evolution of an Epidemic. The class, taught by IMES Professor Bruce Walker and Dr. Howard Heller and offered to MIT undergraduates, examines the medical, scientific, public health and policy responses to a new disease, by…

Measurements could help scientists develop better designs for a bioartificial pancreas. Transplanting pancreatic islet cells into patients with diabetes is a promising alternative to the daily insulin injections that many of these patients now require. These cells could act as a bioartificial pancreas, monitoring blood glucose levels and secreting insulin…